ArticleCirculation2020

VERTIS-CV: More Evidence That Sodium Glucose Cotransporter 2 Inhibition Brings Rapid and Sustained Heart Failure Benefit.

Faiez Zannad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.